Hyperion Defi (HYPD) Inventory (2023 - 2024)
Hyperion Defi (HYPD) posted quarterly Inventory of $3.0 million for Q3 2024, up 5799.59% year-over-year from $50296.0 in Q4 2023, and down 2.78% quarter-over-quarter from $3.1 million in Q2 2024.
Hyperion Defi (HYPD) Inventory (2023 - 2024) Analysis & Trends
Hyperion Defi (HYPD) has reported Inventory for 2 consecutive years, with $3.0 million the latest figure, recorded in Q3 2024.
- In Q3 2024, Inventory rose 5799.59% year-over-year to $3.0 million; the TTM figure through Sep 2024 stood at $3.0 million (up 5799.59% YoY), while the FY2023 annual figure was $109798.0, changed N/A from the prior year.
- Inventory retreated to $3.0 million in Q3 2024 per HYPD's latest filing, from $3.1 million in the prior quarter.
- Across five years, Inventory topped out at $3.5 million in Q1 2024 and bottomed at $50296.0 in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 3.08 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 371.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 280.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 732.60 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 97.11 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 142.38 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 128.86 Mn |
| 10 | Hyperion Defi | 44.65 Mn | 35.01 Mn | 357,693.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 2.97 Mn |
| Jun 30, 2024 | 3.05 Mn |
| Mar 31, 2024 | 3.51 Mn |
| Dec 31, 2023 | 109,798.00 |
| Sep 30, 2023 | 50,296.00 |